C-reactive protein to lymphocyte ratio is a prognostic factor for unfavorable outcomes following aneurysmal subarachnoid hemorrhage
CLR during the hyperacute phase after aSAH might not only be utilized as a reliable biomarker to predict clinical outcomes of aSAH but also provide promising insight into future research to develop tailored treatments targeting inflammation-immune imbalance.
Authors
- Yijun Lin
- Sijia Li
- Xingquan Zhao
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Tian Tan Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
Publication Details
- Journal
- Clinics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.clinsp.2025.100778
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00